Subscribe to Daily Review - your favourite M&A deals update.

Submit Deal

Locust Walk

Summary

Edit Data

Locust Walk is a global life science transaction firm.

Market Context

Deals Overview

Edit Data

Total Deals5

Valued Deals5

Total Value£ 1.32 B

Avg. Deal Size£ 264 M

09 Mar 2025|United States|Pharmaceuticals

Target: CHECKPOINT THERAPEUTICS

Bidder: SUN PHARMACEUTICAL INDUSTRIES LTD

9 Service Providers

6 Target | 3 Bidder

8 Dealmakers

7 Target | 1 Bidder

£ 274 M

Value

07 Mar 2022|United States|Health Care Facilities

Target: VITACARE

Bidder: GOODRX

6 Service Providers

1 Target | 1 Bidder | 4 Vendor

6 Dealmakers

1 Target | 3 Bidder | 2 Vendor

£ 118 M

Value

27 May 2021|United States|Biotechnology

Target: EFFECTOR THERAPEUTICS

Bidder: LOCUST WALK ACQUISITION CORP

21 Service Providers

7 Target | 14 Bidder

33 Dealmakers

23 Target | 10 Bidder

£ 296 M

Value

16 Jun 2020|United States|Biotechnology

Target: C4 THERAPEUTICS INC

Bidder: RTW INVESTMENTS

16 Service Providers

5 Target | 11 Bidder

26 Dealmakers

3 Target | 22 Bidder

£ 119 M

Value

26 Dec 2019|United States|Biotechnology

Target: XYPHOS BIOSCIENCES

Bidder: ASTELLAS PHARMA INC

4 Service Providers

3 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 509 M

Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy